AR130808A1 - 1,3,5-triazinas 2,4,6-trisustituidas como moduladores de cx3cr1 - Google Patents
1,3,5-triazinas 2,4,6-trisustituidas como moduladores de cx3cr1Info
- Publication number
- AR130808A1 AR130808A1 ARP230102794A ARP230102794A AR130808A1 AR 130808 A1 AR130808 A1 AR 130808A1 AR P230102794 A ARP230102794 A AR P230102794A AR P230102794 A ARP230102794 A AR P230102794A AR 130808 A1 AR130808 A1 AR 130808A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heart failure
- haloalkyl
- hydroxy
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se desvelan ciertos compuestos de 1,3,5-triazina 2,4,6-trisustituida de fórmula (1), y sales farmacéuticamente aceptable de las mismas, junto con composiciones que las contienen y su uso en terapia. Los compuestos son moduladores de CX₃CR1 y de ese modo son particularmente útiles en el tratamiento o la profilaxis de trastornos cardiovasculares tales como miocardiopatía dilatada no isquémica e insuficiencia cardíaca. Reivindicación 1: Compuesto de fórmula (1) en donde R¹ es un alquilo C₃₋₆ ramificado o haloalquilo C₃₋₆ ramificado; R² es un alquilo C₁₋₃ o haloalquilo C₁₋₃; m es 1 o 2; R³ y R⁴ se seleccionan independientemente de H, halógeno, alquilo C₁₋₃ y haloalquilo C₁₋₃; A es fenilo, heteroarilo monocíclico, arilo bicíclico o heteroarilo bicíclico; p es 0, 1, 2, 3 o 4; cada R⁵ se selecciona independientemente entre halógeno, hidroxi, oxo, alquilo C₁₋₃, haloalquilo C₁₋₃, alcoxi C₁₋₄, haloalcoxi C₁₋₄, alcoxi C₁₋₄-alquilo C₁₋₃, hidroxialquilo C₁₋₃, -CN, -(CH₂)qCN, -C(O)NR⁶R⁷, -NS(O)R⁶R⁷, -(CH₂)qR⁸, -C(O)R⁸, -C(O)OR⁹, -OC(O)R⁹, -NR⁶C(O)R⁷, -NR⁶R⁷, cicloalquilo C₃₋₆, heteroarilo de 4 - 6 miembros, heterociclilo de 4 - 6 miembros y fenilo, en donde el cicloalquilo C₃₋₆ o heterociclilo de 4 - 6 miembros puede estar opcionalmente sustituido con 1 a 3 sustituyentes seleccionados entre hidroxi, oxi, halógeno y -C(O)OR⁹, el heteroarilo de 4 - 6 miembros puede estar opcionalmente sustituido con 1 a 3 sustituyentes halógeno, el alcoxi C₁₋₄ puede estar opcionalmente sustituido con un heterociclilo de 4 - 6 miembros, cada R⁶ y R⁷ se seleccionan independientemente de H y alquilo C₁₋₃, cada q es independientemente 1, 2 o 3, cada R⁸ es independientemente un heterociclilo de 4 - 6 miembros, en donde el heterociclilo está opcionalmente sustituido con un oxi, y cada R⁹ es independientemente un alquilo C₁₋₅; o una sal farmacéuticamente aceptable o tautómero del mismo. Reivindicación 45: El compuesto de la reivindicación 1, seleccionado de entre: N-(4-(-2-(4-Cianofenil)propil)-6-(((R)-1-hidroxi-4-metilpentan-2-il)amino)-1,3,5-triazin-2-il)metanosulfonamida, N-(4-(2-(4-clorofenil)propil)-6-(((R)-1-hidroxi-4-metilpentan-2-il)amino)-1,3,5-triazin-2-il)metanosulfonamida, y sales y tautómeros farmacéuticamente aceptables del mismo. Reivindicación 47: Un compuesto de cualquiera de las reivindicaciones 1 - 45, o una sal farmacéuticamente aceptable o tautómero del mismo, para su uso en el tratamiento de enfermedades cardiovasculares. Reivindicación 48: El compuesto de la reivindicación 47 en donde la enfermedad cardiovascular es miocardiopatía dilatada no isquémica, insuficiencia cardíaca, enfermedad cardiovascular asociada con afecciones autoinmunes, enfermedad cardiovascular asociada con enfermedades inflamatorias crónicas, insuficiencia cardíaca con fracción de eyección reducida, insuficiencia cardíaca con fracción de eyección levemente reducida, o insuficiencia cardíaca con fracción de eyección conservada.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263417472P | 2022-10-19 | 2022-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR130808A1 true AR130808A1 (es) | 2025-01-22 |
Family
ID=88511235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230102794A AR130808A1 (es) | 2022-10-19 | 2023-10-19 | 1,3,5-triazinas 2,4,6-trisustituidas como moduladores de cx3cr1 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20240199558A1 (es) |
| EP (1) | EP4605388A1 (es) |
| JP (1) | JP2025537492A (es) |
| KR (1) | KR20250086780A (es) |
| CN (1) | CN120077035A (es) |
| AR (1) | AR130808A1 (es) |
| AU (1) | AU2023362450A1 (es) |
| CL (1) | CL2025001155A1 (es) |
| CO (1) | CO2025006339A2 (es) |
| CR (1) | CR20250196A (es) |
| DO (1) | DOP2025000096A (es) |
| IL (1) | IL320305A (es) |
| MX (1) | MX2025004633A (es) |
| PE (1) | PE20251587A1 (es) |
| TW (1) | TW202430188A (es) |
| UY (1) | UY40495A (es) |
| WO (1) | WO2024083933A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20251587A1 (es) * | 2022-10-19 | 2025-06-16 | Astrazeneca Ab | 1,3,5-triazinas 2,4,6-trisustituidas como modulares de cx3cr1 |
| WO2025219939A1 (en) * | 2024-04-17 | 2025-10-23 | Astrazeneca Ab | Salts and polymorphs of cx3cr1 modulators |
| WO2025219950A1 (en) * | 2024-04-18 | 2025-10-23 | Astrazeneca Ab | Small molecule cx3cr1 modulators |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19960683A1 (de) * | 1999-12-15 | 2001-08-23 | Aventis Cropscience Gmbh | Substituierte 2,4-Diamino-1,3,5-triazine, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| SE0101082D0 (sv) | 2001-03-27 | 2001-03-27 | Astrazeneca Ab | Novel use |
| WO2005033115A1 (en) | 2003-10-07 | 2005-04-14 | Astrazeneca Ab | New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| GB0401269D0 (en) | 2004-01-21 | 2004-02-25 | Astrazeneca Ab | Compounds |
| AR053347A1 (es) | 2005-04-06 | 2007-05-02 | Astrazeneca Ab | Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos |
| UA90707C2 (en) | 2005-04-06 | 2010-05-25 | Астразенека Аб | Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| CN101522693B (zh) | 2006-09-29 | 2012-01-04 | 阿斯利康(瑞典)有限公司 | 5,7-二取代的[1,3]噻唑并[4,5-d]嘧啶-2(3h)-胺衍生物和它们在治疗中的用途 |
| TW200820973A (en) | 2006-09-29 | 2008-05-16 | Astrazeneca Ab | Novel compounds 480 |
| AR071036A1 (es) | 2008-03-26 | 2010-05-19 | Astrazeneca Ab | Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1. |
| TWI543975B (zh) | 2011-09-13 | 2016-08-01 | Eisai R&D Man Co Ltd | Pyrrolidin-3-yl acetic acid derivatives |
| EA201591291A1 (ru) | 2013-01-08 | 2015-12-30 | Савира Фармасьютикалз Гмбх | Производные пиримидона и их применение в лечении, облегчении или профилактике вирусного заболевания |
| PE20251587A1 (es) * | 2022-10-19 | 2025-06-16 | Astrazeneca Ab | 1,3,5-triazinas 2,4,6-trisustituidas como modulares de cx3cr1 |
-
2023
- 2023-10-18 PE PE2025000841A patent/PE20251587A1/es unknown
- 2023-10-18 WO PCT/EP2023/079035 patent/WO2024083933A1/en not_active Ceased
- 2023-10-18 EP EP23793744.6A patent/EP4605388A1/en active Pending
- 2023-10-18 AU AU2023362450A patent/AU2023362450A1/en active Pending
- 2023-10-18 US US18/489,184 patent/US20240199558A1/en active Pending
- 2023-10-18 JP JP2025522722A patent/JP2025537492A/ja active Pending
- 2023-10-18 CN CN202380073898.2A patent/CN120077035A/zh active Pending
- 2023-10-18 CR CR20250196A patent/CR20250196A/es unknown
- 2023-10-18 IL IL320305A patent/IL320305A/en unknown
- 2023-10-18 KR KR1020257016242A patent/KR20250086780A/ko active Pending
- 2023-10-19 AR ARP230102794A patent/AR130808A1/es unknown
- 2023-10-19 UY UY0001040495A patent/UY40495A/es unknown
- 2023-10-19 TW TW112139976A patent/TW202430188A/zh unknown
-
2024
- 2024-07-24 US US18/783,231 patent/US12404253B2/en active Active
-
2025
- 2025-04-16 DO DO2025000096A patent/DOP2025000096A/es unknown
- 2025-04-16 CL CL2025001155A patent/CL2025001155A1/es unknown
- 2025-04-21 MX MX2025004633A patent/MX2025004633A/es unknown
- 2025-05-16 CO CONC2025/0006339A patent/CO2025006339A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20240199558A1 (en) | 2024-06-20 |
| UY40495A (es) | 2024-05-15 |
| AU2023362450A1 (en) | 2025-05-29 |
| IL320305A (en) | 2025-06-01 |
| US20240383866A1 (en) | 2024-11-21 |
| DOP2025000096A (es) | 2025-07-15 |
| TW202430188A (zh) | 2024-08-01 |
| US12404253B2 (en) | 2025-09-02 |
| CN120077035A (zh) | 2025-05-30 |
| CL2025001155A1 (es) | 2025-08-29 |
| CR20250196A (es) | 2025-11-21 |
| EP4605388A1 (en) | 2025-08-27 |
| WO2024083933A1 (en) | 2024-04-25 |
| PE20251587A1 (es) | 2025-06-16 |
| KR20250086780A (ko) | 2025-06-13 |
| MX2025004633A (es) | 2025-06-02 |
| JP2025537492A (ja) | 2025-11-18 |
| CO2025006339A2 (es) | 2025-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR120338A1 (es) | Piridazinonas como inhibidores de parp7 | |
| PE20220133A1 (es) | Inhibidores del inflamasoma nlrp3 | |
| AR116978A1 (es) | Fungicidas de tolilo sustituido | |
| AR116913A1 (es) | Inhibidores de apol1 y sus métodos de uso | |
| AR119971A1 (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
| RU2018140092A (ru) | Новые пиразолпиримидиновые производные | |
| AR124193A1 (es) | Compuestos moduladores de rxfp1 | |
| AR094148A1 (es) | Dihidropiridopirazinonas inhibidoras de la proteina bet | |
| AR108906A1 (es) | Heterociclos de biarilmetilo | |
| AR091208A1 (es) | Derivados de piperidina | |
| AR120377A1 (es) | Derivados heteroaromáticos de sulfiliminas o sulfoximinas con actividad fungicida | |
| AR115906A1 (es) | Derivados de haloalilamina sulfona como inhibidores de lisil oxidasas | |
| AR120556A1 (es) | Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso | |
| AR127277A1 (es) | Composiciones y métodos para modular la formación de inclusión y gránulos de estrés | |
| AR116302A1 (es) | Pirazoles fungicidas sustituidos con nitroanilino | |
| AR117228A1 (es) | DERIVADOS DE PIRAZOLO[1,2-a]PIRIDINA, 1H-BENZO[d][1,2,3]TRIAZOL, IMIDAZOPIRIMIDINA Y BENCIMIDAZOL PARA USAR EN EL TRATAMIENTO DE LA INFECCIÓN POR ARENAVIRUS | |
| AR126048A1 (es) | Derivados heterocíclicos condensados | |
| PE20240634A1 (es) | Compuestos triciclicos y usos de los mismos | |
| AR128112A1 (es) | Compuesto, antagonista del receptor de angiotensina ii tipo 1 y composición farmacéutica | |
| PE20221454A1 (es) | Derivados de 2-azaespiro[3.4]octano como agonistas de m4 | |
| AR119980A1 (es) | Composiciones nematicidas | |
| AR093763A1 (es) | Antagonistas de ccr3 de arilsulfonamida isotopicamente enriquecidas | |
| AR131059A1 (es) | Derivados microbicidas de tetrahidroisoquinolina | |
| AR129683A1 (es) | Compuestos herbicidas que contienen imidazol | |
| AR126178A1 (es) | Compuesto, antagonista del receptor de endotelina a y composición farmacéutica |